ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SI vs OFIX // NET PROFIT MARGIN

Shoulder Innovations Inc. (NYSE) VS. Orthofix Medical Inc. (NASDAQ) • 15-METRIC TALLY: SI 5 — OFIX 5
▲ NET PROFIT MARGIN LEADER: OFIX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SI VS. OFIX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SI OFIX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.50% 68.80% +7.70 SI /gross-margins <GO>
Return on Invested Capital (ROIC) -16.10% -12.20% -3.90 OFIX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -8.46% 7.99% -16.45 OFIX /fcf-yield <GO>
Operating Margin -55.60% -9.90% -45.70 OFIX /operating-margins <GO>
Net Profit Margin ACTIVE -60.00% -11.20% -48.80 OFIX /net-margins <GO>
Revenue Growth (YoY) 49.60% 2.90% +46.70 SI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.73 1.02 +7.71 SI /balance-sheet <GO>
Piotroski F-Score Quality 5/9 7/9 -2.00 OFIX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.8 42.3 +8.53 SI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $425.5M $417.1M $8.4M SI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SI REV OFIX REV SI GROSS % OFIX GROSS % SI FCF OFIX FCF
FY 2025 $47.3M $822.3M 76.5% 68.8% -$36.0M $33.3M
FY 2024 $31.6M $799.5M 77.0% 68.3% -$18.2M $25.8M
FY 2023 — $746.6M — — — -$45.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SI // BETA —
OFIX // BETA —